Literature DB >> 21283008

The role of intestinal colonization with gram-negative bacteria as a source for intensive care unit-acquired bacteremia.

Evelien A N Oostdijk1, Anne Marie G A de Smet, Jozef Kesecioglu, Marc J M Bonten.   

Abstract

OBJECTIVE: Selective digestive tract decontamination aims to eradicate gram-negative bacteria in both the intestinal tract and respiratory tract and is combined with a 4-day course of intravenous cefotaxime. Selective oropharyngeal decontamination only aims to eradicate respiratory tract colonization. In a recent study, selective digestive tract decontamination and selective oropharyngeal decontamination were associated with lower day-28 mortality, when compared to standard care. Furthermore, selective digestive tract decontamination was associated with a lower incidence of intensive care unit-acquired bacteremia caused by gram-negative bacteria. We quantified the role of intestinal tract carriage with gram-negative bacteria and intensive care unit-acquired gram-negative bacteremia.
DESIGN: Data from a cluster-randomized and a single-center observational study.
SETTING: Intensive care unit in The Netherlands. PATIENTS: Patients with intensive care unit stay of >48 hrs that received selective digestive tract decontamination (n = 2,667), selective oropharyngeal decontamination (n = 2,166) or standard care (n = 1,945).
INTERVENTIONS: Selective digestive tract decontamination or selective oropharyngeal decontamination.
MEASUREMENTS AND MAIN RESULTS: Incidence densities (episodes/1000 days) of intensive care unit-acquired gram-negative bacteremia were 4.5, 3.0, and 1.4 during standard care, selective oropharyngeal decontamination, and selective digestive tract decontamination, respectively, and the daily risk for developing intensive care unit-acquired gram-negative bacteria bacteremia increased until days 36, 33, and 31 for selective digestive tract decontamination, standard care, and selective oropharyngeal decontamination and was always lowest during selective digestive tract decontamination. Rectal colonization with gram-negative bacteria was present in 26% and 71% of patient days during selective digestive tract decontamination and selective oropharyngeal decontamination, respectively (p < .01). Irrespective of interventions, incidence densities of intensive care unit-acquired gram-negative bacteremia was 4.5 during patient days with both intestinal and respiratory tract gram-negative bacteria carriage. These incidence densities reduced with 33% (to 3.1) during days with intestinal gram-negative bacteria carriage only and with another 45% (to 1.0) during days without gram-negative bacteria carriage at both sites.
CONCLUSIONS: Respiratory tract decolonization was associated with a 33% and intestinal tract decolonization was associated with a 45% reduction in the occurrence of intensive care unit-acquired gram-negative bacteremia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21283008     DOI: 10.1097/CCM.0b013e318208ee26

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model.

Authors:  Krishnan MohanKumar; Niroop Kaza; Ramasamy Jagadeeswaran; Steven A Garzon; Anchal Bansal; Ashish R Kurundkar; Kopperuncholan Namachivayam; Juan I Remon; C Rekha Bandepalli; Xu Feng; Joern-Hendrik Weitkamp; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-26       Impact factor: 4.052

2.  Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.

Authors:  Eva-Brigitta Kruse; Ute Aurbach; Hilmar Wisplinghoff
Journal:  Curr Infect Dis Rep       Date:  2013-10-12       Impact factor: 3.725

3.  Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of Sepsis.

Authors:  John C Alverdy; Monika A Krezalek
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 4.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

5.  Positive urinary antigen tests for Streptococcus pneumoniae in community-acquired pneumonia: a 7-year retrospective evaluation of health care cost and treatment consequences.

Authors:  M F Engel; M van Velzen; A I M Hoepelman; S Thijsen; J J Oosterheert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-31       Impact factor: 3.267

6.  The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research.

Authors:  Nasia Safdar; Deverick J Anderson; Barbara I Braun; Philip Carling; Stuart Cohen; Curtis Donskey; Marci Drees; Anthony Harris; David K Henderson; Susan S Huang; Manisha Juthani-Mehta; Ebbing Lautenbach; Darren R Linkin; Jennifer Meddings; Loren G Miller; Aaron Milstone; Daniel Morgan; Sharmila Sengupta; Meera Varman; Deborah Yokoe; Danielle M Zerr
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05       Impact factor: 3.254

7.  Selective decontamination in European intensive care patients.

Authors:  Evelien A N Oostdijk; Bastiaan H J Wittekamp; Christian Brun-Buisson; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2012-04       Impact factor: 17.440

Review 8.  Topical antibiotics as a major contextual hazard toward bacteremia within selective digestive decontamination studies: a meta-analysis.

Authors:  James C Hurley
Journal:  BMC Infect Dis       Date:  2014-12-31       Impact factor: 3.090

9.  Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.

Authors:  Etienne Ruppé; Antoine Andremont
Journal:  Front Microbiol       Date:  2013-05-28       Impact factor: 5.640

10.  Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract.

Authors:  Luca Badiali; Jonathan Cedernaes; Pawel K Olszewski; Olof Nylander; Anna V Vergoni; Helgi B Schiöth
Journal:  BMC Gastroenterol       Date:  2012-09-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.